Oil-in-water emulsions for topical administration with hyaluronan

The USPTO has published a patent application (US20260083673A1) for oil-in-water emulsions containing hyaluronan for topical administration. The application details formulations for treating various dermatological conditions, including inflammatory dermatoses, acne, alopecia, and fibrosing pathologies.

Patent Application for Stabilized Galectin-9 Protein Pharmaceutical Formulation

The USPTO has published a patent application (US20260083671A1) for a stabilized pharmaceutical formulation containing a recombinant stabilized galectin-9 protein. The application details a formulation designed for improved stability through the combination of a buffer and a stabilizer.

Adenovirus Formulation with Citrate Buffer and Salt

The USPTO has published a new patent application (US20260083670A1) for an adenovirus formulation. The formulation includes a recombinant adenovirus, citrate buffer, cyclodextrin compound, and salt, with a pH between 5.5 and 6.5, and is free of non-ionic detergent. The invention also covers a method for preserving adenoviruses using this formulation.

Aqueous Gel Composition for Administering Active Agents

The USPTO has published a new patent application, US20260083669A1, filed by Acousia Therapeutics GmbH. The application describes an aqueous gel composition useful for administering pharmaceutically active agents, particularly for transtympanic administration.

USPTO Patent for Orally Administered Corticosteroid Compositions

The USPTO has published a new patent application, US20260083668A1, for orally administered corticosteroid compositions. The patent, filed on November 28, 2025, by inventors Stephen Perrett, Fredric Jay Cohen, and Gopi M. Venkatesh, details pharmaceutical compositions and methods for treating gastrointestinal inflammation.

Sulforaphane Supplement in Gummy Form Patent Application

The USPTO has published a patent application (US20260083667A1) for a sulforaphane supplement in gummy form. The application, filed by Sensory Scout LLC, describes a composition including sulforaphane, glucoraphanin, and myrosinase immobilized within a gummy matrix. This represents a new patent filing for a novel supplement formulation.

USPTO Patent Application for Disease Treatment Method

The USPTO has published patent application US20260083666A1 for a method of treating diseases and ameliorating pain by administering a composition to the ear canal. The application was filed on April 10, 2025, and published on March 26, 2026.

USPTO Patent for Implantable Biodegradable Drug Delivery Devices

The USPTO has published a patent application (US20260083665A1) for implantable and biodegradable drug delivery devices. The invention aims to deliver active pharmaceutical ingredients directly to target tissue sites using layered biodegradable polymers.

Patent Application: Intrathecal T regulatory cells for Multiple Sclerosis Treatment

The USPTO has published a patent application (US20260083664A1) for a medicinal product involving intrathecal administration of T regulatory cells for treating multiple sclerosis. The application was filed on December 3, 2025, by inventors Piotr Trzonkowski and Kamil Chwojnicki.

Botanical Compositions and Methods of Production and Use

The USPTO has published a new patent application, US20260083663A1, detailing botanical compositions with plant extracts and their preparation methods. The application was filed on September 11, 2023, and is scheduled for publication on March 26, 2026. This represents a new disclosure of potential intellectual property in the pharmaceutical sector.